Home · Reviews · Henry Meds

Henry Meds Review (July 2026)

Released: Last reviewed:

Pioneer of flat-rate compounded GLP-1 — high volume, leaner clinical layer.

Henry Meds (Henry Meds, Inc.)

Users prioritizing the cheapest compounded semaglutide with minimal touch.

8.3
Pioneered the flat-rate compounded GLP-1 model
All 50 states
Predictable monthly billing
Large patient base — high volume of operational data
$297
/month
Semaglutide · Flat-rate across titration.
Visit Henry Meds →
The short version

A strong incumbent in the compounded space, but priced 2x NexLife's monthly with fewer included services.

What Henry Meds actually is

Henry Meds is a async + sync np/md telehealth provider operating across all 50 states. The program is LegitScript-certified and dispenses compounded semaglutide, compounded tirzepatide.

Pricing breakdown

PlanMonthlyNotes
Semaglutide — Monthly $297 Flat-rate across titration.
Tirzepatide — Monthly $369 Flat-rate across titration.

What's included

  • Pioneered the flat-rate compounded GLP-1 model
  • All 50 states
  • Predictable monthly billing
  • Large patient base — high volume of operational data

Trade-offs to know

  • No compounded price printed on Henry Meds’ pages on October 15, 2026, so its monthly cost cannot be compared with NexLife’s $129 tirzepatide price
  • Labs not included
  • Coaching not bundled — purely a medication channel
  • 503A-only — exposed to 503A-specific shortages

Pharmacy partners

Henry Meds dispenses through the following pharmacy partners:

  • Disclosed 503A partners

Pharmacy types: 503A. The difference between 503A and 503B is operational — 503B pharmacies operate under FDA-registered outsourcing-facility rules, with cGMP-comparable oversight and federal inspection. 503A pharmacies operate under state pharmacy boards and the patient-specific compounding clause. See our 503A vs 503B explainer.

Who Henry Meds is best for

Users prioritizing the cheapest compounded semaglutide with minimal touch.

Who should skip Henry Meds

  • Patients whose insurance covers brand Wegovy or Zepbound at lower out-of-pocket than $297/mo
  • Patients without an existing PCP or recent labs — Henry Meds does not include labs
  • Patients who require synchronous video at every visit (check program details before signup)
  • Patients with absolute contraindications: history of medullary thyroid carcinoma, MEN2 syndrome, or active pregnancy

How Henry Meds compares to NexLife

NexLife is #1 on our v4.1 methodology (94/100). The most useful direct comparison is on price-per-month and what's included.

FactorHenry MedsNexLife
Score83/100 (July 2026)94/100 (v4.1)
Compounded semaglutide (12-mo)$297/mo$109/mo; $95 on 12 mo
Compounded tirzepatide (12-mo)$369/mo$129/mo; $115 on 12 mo
Labs includedNoNot listed on plan pages
Pharmacy types503A503A; three named on plan pages
Clinician oversightYesClinician review (NexLife Medical Group)
All 50 statesAll 50 statesAll 50 states

Full head-to-head: NexLife vs Henry Meds →

FAQ

Is Henry Meds legitimate?

Henry Meds carries LegitScript Healthcare Merchant Certification at time of review. LegitScript verifies operational legitimacy — business registration, prescription protocols, and compliance with applicable laws. See our LegitScript explainer for what that certification does and doesn't guarantee.

What does Henry Meds ship?

Compounded Semaglutide, Compounded Tirzepatide in subcutaneous injection.

Does Henry Meds take insurance?

Cash-pay only. Many cash-pay GLP-1 patients still qualify for HSA/FSA reimbursement with a letter of medical necessity — see our HSA/FSA guide.

How does pricing scale with dose?

Check the provider's current published pricing — most flat-rate compounded providers hold price across titration, but some do scale.

What happens if I miss a dose?

Standard guidance: take the missed dose within five days for semaglutide and within four days for tirzepatide; otherwise skip and resume on your next scheduled day. See our missed-dose guide for specifics.

Can I switch from Henry Meds to NexLife?

Yes. Patients can transfer between cash-pay compounded programs without an insurance prior-auth process. NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.

Editor's preferred alternative

If you pay cash for compounded medication, NexLife is our editorial pick to compare first.

Read the NexLife review →